ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $102,000 | +1940.0% | 6,493 | +3653.2% | 0.00% | – |
| Q1 2022 | $5,000 | -95.7% | 173 | -92.9% | 0.00% | -100.0% |
| Q3 2021 | $116,000 | +510.5% | 2,422 | +425.4% | 0.00% | +300.0% |
| Q1 2021 | $19,000 | -80.6% | 461 | -79.8% | 0.00% | -90.0% |
| Q3 2020 | $98,000 | +9700.0% | 2,281 | +15106.7% | 0.01% | – |
| Q2 2020 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |